Abbott Laboratories Earnings Dividend

Abbott Laboratories’s revenue jumped 13.02% since last year same period to $12593Mn in the Q2 2026. On a quarterly growth basis, Abbott Laboratories has generated 12.8% jump in its revenue since last 3-months.

Abbott Laboratories’s net profit fell -47.84% since last year same period to $928Mn in the Q2 2026. On a quarterly growth basis, Abbott Laboratories has generated -13.83% fall in its net profits since last 3-months.

Abbott Laboratories’s net profit margin fell -53.85% since last year same period to 7.37% in the Q2 2026. On a quarterly growth basis, Abbott Laboratories has generated -23.61% fall in its net profit margins since last 3-months.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.42 - a 10.94% jump from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.42.

Abbott Laboratories’s earning per share (EPS) jumped 3.97% since last year same period to 1.31 in the Q2 2026. This indicates that the Abbott Laboratories has generated 3.97% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.63 dividend per share during the earnings announcement for Q2 2026.